Patents by Inventor Katrina Steiling

Katrina Steiling has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210113581
    Abstract: The technology described herein is directed to methods and compositions for prognosis and treatment of respiratory disease, e.g., COPD.
    Type: Application
    Filed: October 15, 2020
    Publication date: April 22, 2021
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Elizabeth Jeanne BECKER, Katrina STEILING, Avrum E. SPIRA, Marc E. LENBURG
  • Patent number: 10533225
    Abstract: A novel set of 98 genes expressed in the respiratory tract epithelium that serve as biomarkers for measuring chronic obstructive pulmonary disease (COPD) activity are provided. Methods of classifying the (COPD) status of a subject are provided. Systems for expression-based classification of COPD disease status are provided. Methods of treating COPD are also provided, among other things.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: January 14, 2020
    Assignees: TRUSTEES OF BOSTON UNIVERSITY, THE BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Katrina Steiling, Avrum Spira, Marc Lenberg, Stephen Lam
  • Publication number: 20170275695
    Abstract: A novel set of 98 genes expressed in the respiratory tract epithelium that serve as biomarkers for measuring chronic obstructive pulmonary disease (COPD) activity are provided. Methods of classifying the (COPD) status of a subject are provided. Systems for expression-based classification of COPD disease status are provided. Methods of treating COPD are also provided, among other things.
    Type: Application
    Filed: June 8, 2017
    Publication date: September 28, 2017
    Applicants: Trustees of Boston University, THE BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Katrina STEILING, Avrum SPIRA, Marc LENBERG, Stephen LAM
  • Patent number: 9677138
    Abstract: A novel set of 98 genes expressed in the respiratory tract epithelium that serve as biomarkers for measuring chronic obstructive pulmonary disease (COPD) activity are provided. Methods of classifying the (COPD) status of a subject are provided. Systems for expression-based classification of COPD disease status are provided. Methods of treating COPD are also provided, among other things.
    Type: Grant
    Filed: May 20, 2013
    Date of Patent: June 13, 2017
    Assignees: TRUSTEES OF BOSTON UNIVERSITY, THE BRITISH COLUMBIA CANCER AGENCY BRANCH
    Inventors: Katrina Steiling, Avrum Spira, Marc Lenberg, Stephen Lam
  • Publication number: 20150240306
    Abstract: A novel set of 98 genes expressed in the respiratory tract epithelium that serve as biomarkers for measuring chronic obstructive pulmonary disease (COPD) activity are provided. Methods of classifying the (COPD) status of a subject are provided. Systems for expression-based classification of COPD disease status are provided. Methods of treating COPD are also provided, among other things.
    Type: Application
    Filed: May 20, 2013
    Publication date: August 27, 2015
    Applicant: TRUSTEES OF BOSTON UNIVERSITY
    Inventors: Katrina Steiling, Avrum Spira, Marc Lenberg, Stephen Lam